Tags

Type your tag names separated by a space and hit enter

[Effect of "Yinqi Guiyuan" needling on primary insomnia].
Zhen Ci Yan Jiu. 2019 Nov 25; 44(11):840-2.ZC

Abstract

OBJECTIVE

To observe the clinical effect of "Yinqi Guiyuan" needling in the treatment of primary insomnia.

METHODS

A total of 79 primary insomnia outpatients were randomly divided into treatment group (n=40) and control group (n=39). The patients in the control group were given oral Estazolam tablets once a day, for successive 4 weeks. For patients of the treatment group, Zhongwan (CV12), Xiawan (CV10), Qihai (CV6), Guanyuan (CV4), Baihui (GV20), etc., were punctured with filiform needles for 30 min. The treatment was conducted three times per week for 4 successive weeks. The sleep quality (sleeping quality, falling asleep time, sleep duration, sleep efficiency, sleep disorders, hypnotic and daytime dysfunction, 0 to 21 points) was evaluated by using Pittsburgh Sleep Quality Index (PSQI). The severity of insomnia (self-perception, sleep satisfaction, daytime function damage, sensibility change, and concern for sleep problems, 0 to 28 points) was assessed using insomnia severity index (ISI) score. The therapeutic effect was evaluated according to the PSQI score reduction rate = (pre-treatment PSQI score-post-treatment PSQI score)/pre-treatment PSQI score ×100%.

RESULTS

After treatment, the total score of PSQI, ISI and the score of each item were all significantly reduced in the two groups relevant to their own pre-treatment (P<0.05). The total score, and scores of hypnotic and daytime dysfunction were significantly lower in the treatment group than in the control group (P<0.05). Of the 40 and 39 cases in the treatment and control groups, 5 (12.50%) and 4 (10.25%) were cured, 20 (50.00%) and 18 (46.15%) experienced marked improvement, 12 (30.00%) and 13 (33.33%) were effective, and 3 (7.50%) and 4 (10.25%) ineffective, with the total effective rate being 92.50% and 89.74%, respectively. No significant difference was found between the two groups in the effective rate (P>0.05).

CONCLUSION

"Yinqi Guiyuan" needling and Estazolam are comparable in treatment primary insomnia, and the former is superior to the latter in avoiding hypnotic drug use and in improving daytime function.

Authors+Show Affiliations

Department of Encephalopathy, Shenzhen Hospital of Traditional Chinese Medicine, Shenzhen 518000, Guangdong Province, China.Bipolar Disorder Department, Corning Hospital of Shenzhen, Shenzhen 518000, Guangdong Province.Department of Encephalopathy, Shenzhen Hospital of Traditional Chinese Medicine, Shenzhen 518000, Guangdong Province, China.Department of Encephalopathy, Shenzhen Hospital of Traditional Chinese Medicine, Shenzhen 518000, Guangdong Province, China.Department of Encephalopathy, Shenzhen Hospital of Traditional Chinese Medicine, Shenzhen 518000, Guangdong Province, China.Department of Encephalopathy, Shenzhen Hospital of Traditional Chinese Medicine, Shenzhen 518000, Guangdong Province, China.Department of Encephalopathy, Shenzhen Hospital of Traditional Chinese Medicine, Shenzhen 518000, Guangdong Province, China.

Pub Type(s)

Journal Article
Randomized Controlled Trial

Language

chi

PubMed ID

31777236

Citation

Guan, Tian-Xiang, et al. "[Effect of "Yinqi Guiyuan" Needling On Primary Insomnia]." Zhen Ci Yan Jiu = Acupuncture Research, vol. 44, no. 11, 2019, pp. 840-2.
Guan TX, Xu YF, Lin SJ, et al. [Effect of "Yinqi Guiyuan" needling on primary insomnia]. Zhen Ci Yan Jiu. 2019;44(11):840-2.
Guan, T. X., Xu, Y. F., Lin, S. J., Qin, X. D., Li, J. F., Huang, B. Q., & Guo, Z. K. (2019). [Effect of "Yinqi Guiyuan" needling on primary insomnia]. Zhen Ci Yan Jiu = Acupuncture Research, 44(11), 840-2. https://doi.org/10.13702/j.1000-0607.180330
Guan TX, et al. [Effect of "Yinqi Guiyuan" Needling On Primary Insomnia]. Zhen Ci Yan Jiu. 2019 Nov 25;44(11):840-2. PubMed PMID: 31777236.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Effect of "Yinqi Guiyuan" needling on primary insomnia]. AU - Guan,Tian-Xiang, AU - Xu,Ying-Fen, AU - Lin,Song-Jun, AU - Qin,Xiu-de, AU - Li,Jin-Fang, AU - Huang,Bin-Qing, AU - Guo,Zhou-Ke, PY - 2019/11/29/entrez PY - 2019/11/30/pubmed PY - 2019/12/4/medline KW - Estazolam KW - Primary insomnia KW - “Yinqi Guiyuan” needling SP - 840 EP - 2 JF - Zhen ci yan jiu = Acupuncture research JO - Zhen Ci Yan Jiu VL - 44 IS - 11 N2 - OBJECTIVE: To observe the clinical effect of "Yinqi Guiyuan" needling in the treatment of primary insomnia. METHODS: A total of 79 primary insomnia outpatients were randomly divided into treatment group (n=40) and control group (n=39). The patients in the control group were given oral Estazolam tablets once a day, for successive 4 weeks. For patients of the treatment group, Zhongwan (CV12), Xiawan (CV10), Qihai (CV6), Guanyuan (CV4), Baihui (GV20), etc., were punctured with filiform needles for 30 min. The treatment was conducted three times per week for 4 successive weeks. The sleep quality (sleeping quality, falling asleep time, sleep duration, sleep efficiency, sleep disorders, hypnotic and daytime dysfunction, 0 to 21 points) was evaluated by using Pittsburgh Sleep Quality Index (PSQI). The severity of insomnia (self-perception, sleep satisfaction, daytime function damage, sensibility change, and concern for sleep problems, 0 to 28 points) was assessed using insomnia severity index (ISI) score. The therapeutic effect was evaluated according to the PSQI score reduction rate = (pre-treatment PSQI score-post-treatment PSQI score)/pre-treatment PSQI score ×100%. RESULTS: After treatment, the total score of PSQI, ISI and the score of each item were all significantly reduced in the two groups relevant to their own pre-treatment (P<0.05). The total score, and scores of hypnotic and daytime dysfunction were significantly lower in the treatment group than in the control group (P<0.05). Of the 40 and 39 cases in the treatment and control groups, 5 (12.50%) and 4 (10.25%) were cured, 20 (50.00%) and 18 (46.15%) experienced marked improvement, 12 (30.00%) and 13 (33.33%) were effective, and 3 (7.50%) and 4 (10.25%) ineffective, with the total effective rate being 92.50% and 89.74%, respectively. No significant difference was found between the two groups in the effective rate (P>0.05). CONCLUSION: "Yinqi Guiyuan" needling and Estazolam are comparable in treatment primary insomnia, and the former is superior to the latter in avoiding hypnotic drug use and in improving daytime function. SN - 1000-0607 UR - https://www.unboundmedicine.com/medline/citation/31777236/[Effect_of_"Yinqi_Guiyuan"_needling_on_primary_insomnia]_ L2 - https://medlineplus.gov/insomnia.html DB - PRIME DP - Unbound Medicine ER -